Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Biomaterials
|
August 27, 2002
Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel
Adam A Dinerman, Joseph Cappello, Hamidreza Ghandehari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 15, 2002
Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels
Adam A Dinerman, Joseph Cappello, Hamidreza Ghandehari, et al.
Macromolecular Bioscience
|
July 6, 2010
Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel
Adam A Dinerman, Joseph Cappello, Mohamed El-Sayed, et al.
Journal of Pharmaceutical Sciences
|
February 1, 2011
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies
Todd J Gibson, Katie Mccarty, Iain J Mcfadyen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Biomaterials
|
August 27, 2002
Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel
Adam A Dinerman, Joseph Cappello, Hamidreza Ghandehari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 15, 2002
Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels
Adam A Dinerman, Joseph Cappello, Hamidreza Ghandehari, et al.
Macromolecular Bioscience
|
July 6, 2010
Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel
Adam A Dinerman, Joseph Cappello, Mohamed El-Sayed, et al.
Journal of Pharmaceutical Sciences
|
February 1, 2011
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies
Todd J Gibson, Katie Mccarty, Iain J Mcfadyen, et al.
Page
of 1